Cargando…

Letter to the Editor Concerning “Study on the Application of Systemic Inflammation Response Index and Platelet–Lymphocyte Ratio in Ovarian Malignant Tumors” [Letter]

Detalles Bibliográficos
Autores principales: Huang, Honglian, Huang, Tao, Wei, Renjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747763/
https://www.ncbi.nlm.nih.gov/pubmed/35023958
http://dx.doi.org/10.2147/IJGM.S354920
_version_ 1784630906933215232
author Huang, Honglian
Huang, Tao
Wei, Renjie
author_facet Huang, Honglian
Huang, Tao
Wei, Renjie
author_sort Huang, Honglian
collection PubMed
description
format Online
Article
Text
id pubmed-8747763
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-87477632022-01-11 Letter to the Editor Concerning “Study on the Application of Systemic Inflammation Response Index and Platelet–Lymphocyte Ratio in Ovarian Malignant Tumors” [Letter] Huang, Honglian Huang, Tao Wei, Renjie Int J Gen Med Letter Dove 2022-01-06 /pmc/articles/PMC8747763/ /pubmed/35023958 http://dx.doi.org/10.2147/IJGM.S354920 Text en © 2022 Huang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Letter
Huang, Honglian
Huang, Tao
Wei, Renjie
Letter to the Editor Concerning “Study on the Application of Systemic Inflammation Response Index and Platelet–Lymphocyte Ratio in Ovarian Malignant Tumors” [Letter]
title Letter to the Editor Concerning “Study on the Application of Systemic Inflammation Response Index and Platelet–Lymphocyte Ratio in Ovarian Malignant Tumors” [Letter]
title_full Letter to the Editor Concerning “Study on the Application of Systemic Inflammation Response Index and Platelet–Lymphocyte Ratio in Ovarian Malignant Tumors” [Letter]
title_fullStr Letter to the Editor Concerning “Study on the Application of Systemic Inflammation Response Index and Platelet–Lymphocyte Ratio in Ovarian Malignant Tumors” [Letter]
title_full_unstemmed Letter to the Editor Concerning “Study on the Application of Systemic Inflammation Response Index and Platelet–Lymphocyte Ratio in Ovarian Malignant Tumors” [Letter]
title_short Letter to the Editor Concerning “Study on the Application of Systemic Inflammation Response Index and Platelet–Lymphocyte Ratio in Ovarian Malignant Tumors” [Letter]
title_sort letter to the editor concerning “study on the application of systemic inflammation response index and platelet–lymphocyte ratio in ovarian malignant tumors” [letter]
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747763/
https://www.ncbi.nlm.nih.gov/pubmed/35023958
http://dx.doi.org/10.2147/IJGM.S354920
work_keys_str_mv AT huanghonglian lettertotheeditorconcerningstudyontheapplicationofsystemicinflammationresponseindexandplateletlymphocyteratioinovarianmalignanttumorsletter
AT huangtao lettertotheeditorconcerningstudyontheapplicationofsystemicinflammationresponseindexandplateletlymphocyteratioinovarianmalignanttumorsletter
AT weirenjie lettertotheeditorconcerningstudyontheapplicationofsystemicinflammationresponseindexandplateletlymphocyteratioinovarianmalignanttumorsletter